arXiv · 2511.19677
Clarifying identification and estimation of treatment effects in the Sequential Parallel Comparison Design
Abstract
Sequential parallel comparison design (SPCD) clinical trials aim to adjust active treatment effect estimates for placebo response to minimize the impact of placebo responders on the estimates. This is potentially accomplished using a two stage design by measuring treatment effects among all participants during the first stage, then classifying some placebo arm participants as placebo non-responders who will be re-randomized in the second stage. In this paper, we use causal inference tools to clarify under what assumptions treatment effects can be identified in SPCD trials and what effects the conventional estimators target at each stage of the SPCD trial. We further illustrate the highly influential impact of placebo response misclassification on the second stage estimate. We conclude that the conventional SPCD estimators do not target meaningful treatment effects.
Explore related subjects
Keep this discovery
Benjamin Stockton, Michele Santacatterina, Soutrik Mandal, Charles M. Cleland, Erinn M. Hade, Nicholas Illenberger, Sharon Meropol, Andrea B. Troxel, Eva Petkova, Chang Yu, Thaddeus Tarpey. 2025-11-24. Clarifying identification and estimation of treatment effects in the Sequential Parallel Comparison Design. https://arxiv.org/abs/2511.19677
Cite the original work for its findings. Save a collection to share your selection of sources.